NasdaqCM - Nasdaq Real Time Price USD

Nuvectis Pharma, Inc. (NVCT)

8.85
-0.12
(-1.34%)
At close: June 6 at 4:00:00 PM EDT
8.85
0.00
(0.00%)
After hours: June 6 at 4:04:06 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
21,019
19,847
22,897
19,234
12,894
Operating Income
-21,019
-19,847
-22,897
-19,234
-12,894
Net Non Operating Interest Income Expense
858
847
637
149
4
Pretax Income
-20,161
-19,000
-22,260
-19,085
-12,890
Net Income Common Stockholders
-20,161
-19,000
-22,260
-19,085
-12,890
Diluted NI Available to Com Stockholders
-20,161
-19,000
-22,260
-19,085
-12,890
Basic EPS
-1.13
-1.11
-1.43
-1.51
-1.09
Diluted EPS
-1.13
-1.11
-1.43
-1.51
-1.09
Basic Average Shares
17,957.71
17,113.17
15,556.66
12,657.65
12,717.79
Diluted Average Shares
17,957.71
17,113.17
15,556.66
12,657.65
12,717.79
Total Operating Income as Reported
-21,019
-19,847
-22,897
-19,234
-12,894
Total Expenses
21,019
19,847
22,897
19,234
12,894
Net Income from Continuing & Discontinued Operation
-20,161
-19,000
-22,260
-19,085
-12,890
Normalized Income
-20,161
-19,000
-22,260
-19,085
-12,890
Interest Income
858
847
637
149
4
Net Interest Income
858
847
637
149
4
EBIT
-21,019
-19,847
-22,897
-19,234
-12,894
EBITDA
-21,019
-19,847
-22,897
-19,234
-12,894
Net Income from Continuing Operation Net Minority Interest
-20,161
-19,000
-22,260
-19,085
-12,890
Normalized EBITDA
-21,019
-19,847
-22,897
-19,234
-12,894
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 2/4/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CGEM Cullinan Therapeutics, Inc.
9.08
+3.89%
 
ELDN Eledon Pharmaceuticals, Inc.
3.0800
+3.36%
 
AARD Aardvark Therapeutics, Inc.
11.81
-1.17%
 
ENTX Entera Bio Ltd.
2.0700
+2.99%
 
NAUT Nautilus Biotechnology, Inc.
0.7690
+3.64%
 
VYNE VYNE Therapeutics Inc.
1.0000
0.00%
 
LXEO Lexeo Therapeutics, Inc.
3.8800
+18.65%
 
NKTR Nektar Therapeutics
9.99
+1,380.44%
 
SLRN Acelyrin, Inc.
2.2700
0.00%
 
COYA Coya Therapeutics, Inc.
5.88
+3.16%